Modified Pfizer Omicron-Based Vaccine Boosts Defense Against Variant? FDA To Discuss Tweaked COVID-19 Medicine Modified Pfizer Omicron-based vaccine is claimed to boost defense against the contagious variant. FDA will soon discuss the use of this updated COVID-19 vaccine. by Griffin Davis
Health Pfizer 4th COVID-19 Vaccine Shot Data: Findings Show Booster's Efficiency Disappears After Four Months by Griffin Davis
Health Pfizer COVID Vaccine: FDA Approval for Use on Children Ages 6 Mos. to 4 Years Old Now Processing by Isaiah Richard
Health Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety by Griffin Davis
Health Redesigned Pfizer Vaccine for COVID-19 Omicron Variant to Arrive by March — Pfizer CEO by Griffin Davis
Health COVID-19 Vaccine for Kids: Pfizer Asks FDA for EUA for Administration to Ages 5 to 11 by Isaiah Richard
Health Pfizer Vaccine Eligibility: 12 to 15 Year Olds to Receive Shots for COVID-19 by Wed, May 12 by Isaiah Richard